Mice Model Market Worth USD 2,289.5 Million by 2026

1. Mice Model Market Worth USD 2,289.5 Million by 2026 “Global Mice Model Market By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Conditioned/Surgically Modified Mice, Others), By Service (Breeding, Cryopreservation, Quarantine, Genetic Testing, Others), By Technology (Crispr/Cas9 Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection, Others), By Application (Oncology Studies, Immunology and Inflammation Studies, Diabetes Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Other Disease Studies) and Region- Global Market Size, Status and Forecast to 2026″, published by Verified Market Research. The Global Mice Model Market size is projected to grow from USD 1,282.7 Million in 2018 to USD 2,289.5 Million by 2026, at a CAGR of 7.65% from 2019 to 2026. The market is growing on the account of the upsurge in the number of pharmaceutical R&D activities. Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download- sample/?rid=6874&utm_source=Free&utm_medium=004 Browse in-depth TOC on “Global Mice Model Market” 92 – Tables 42 – Figures 118 – Pages On the basis of type, the market is bifurcated into Inbred Mice, Outbred Mice, Genetically Engineered Mice, Conditioned/Surgically Modified Mice, and Others. Inbred Mice segment is expected to have the largest market share of the market. Inbred mice are strains that have been maintained for over more than 20 generations by successive brother to sister mating. Inbred mice are used as an animal model by the research scientists to provide standardized tools for designing and conducting a wide variety of experiments related to human health and disease. These mice are genetically stable and cannot be altered by selective breeding. An increase in the number of pharmaceutical research and development activities is expected to drive the market. The advancement of pharmaceutical drug discovery and development has become progressively more challenging over the years. With the use of technology, there have been a significant number of breakthroughs that have facilitated various research processes through which there has been the identification of the causes of diseases. The pharmaceutical industry’s business model essentially revolves around productive innovation that is to create value by delivering customer benefits. It is also important to remember that sustainable growth and value creation depends on steady R&D productivity. Get More Information @ –https://www.verifiedmarketresearch.com/download- sample/?rid=6874&utm_source=Free&utm_medium=004 The North America region is projected to account for the largest share in the Global Mice Model market during the forecast period. This is attributed to the rising frequency of cancer and research grants favoring the adoption of mice models. North America’s large share is also attributed to the growing demands for monoclonal antibody production as well as continued and responsible use of animals ensured by animal care organizations. Moreover, due to the tremendous research and development activities that are ongoing in the sector further boost the growth of the market in this region.

2. Key players Charles River Laboratories International, Inc., The Jackson Laboratory, Janvier Labs, Harbour Antibodies BV, ENVIGO and Laboratory Corporation of America Holdings. are the key players operating in the Global Mice Model Market. Acquisitions and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Global Mice Model Market. Obtain Report Details @ https://www.verifiedmarketresearch.com/press-release/mice-model- market/?utm_source=Free&utm_medium=004